Section one: Contracting authority
one.1) Name and addresses
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf
London
E14 4PU
Country
United Kingdom
NUTS code
UK - UNITED KINGDOM
Internet address(es)
Main address
https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://mhra.bravosolution.co.uk/
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://mhra.bravosolution.co.uk/
Tenders or requests to participate must be submitted to the above-mentioned address
one.4) Type of the contracting authority
National or federal Agency/Office
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Single cell sequencing system
two.1.2) Main CPV code
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
two.1.3) Type of contract
Supplies
two.1.4) Short description
The Agency would like to purchase a new high-throughput platform for single-cell isolation, barcoding, and subsequent analysis via next-generation sequencing on an Illumina NextSeq 500 sequencer.
The main application will be RNA-Seq and the minimum number of cells processed per run should be >10,000. Quick laboratory workflows and compatibility of the system with a wide range of input samples such as fresh, frozen and fixed, would be beneficial.
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
The Agency would like to purchase a new high-throughput platform for single-cell isolation, barcoding, and subsequent analysis via next-generation sequencing on an Illumina NextSeq 500 sequencer.
The main application will be RNA-Seq and the minimum number of cells processed per run should be >10,000. Quick laboratory workflows and compatibility of the system with a wide range of input samples such as fresh, frozen and fixed, would be beneficial.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
60
This contract is subject to renewal
Yes
Description of renewals
This is a one off purchase with a maintenance contract for a period of 5 years with a possible extension till the end of the life of the equipment. This will be one year after the purchase of the equipment.
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions
Please see Supplier Questionnaire on https://mhra.bravosolution.co.uk
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
5 March 2021
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.7) Conditions for opening of tenders
Date
8 March 2021
Local time
2:00pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.4) Procedures for review
six.4.1) Review body
Medicines and Healthcare products Regulatory Agency
London
Country
United Kingdom